Signpath Pharma, Inc. (SGTH) financial statements (2020 and earlier)

Company profile

Business Address 3477 CORPORATE PARKWAY, SUITE 100
CENTER VALLEY, PA 18034
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6927161,24132
Cash and cash equivalents6927161,24132
Prepaid expense5  
Total current assets:6987161,24132
Noncurrent Assets
Property, plant and equipment  50
Other undisclosed noncurrent assets  (5) 
Total noncurrent assets:   0
TOTAL ASSETS:6987161,24132
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:310448422894
Accrued liabilities8675  
Interest and dividends payable1,730   
Other undisclosed accounts payable and accrued liabilities(1,506)373422894
Derivative instruments and hedges, liabilities   5,687
Other undisclosed current liabilities   862
Total current liabilities:3104484227,444
Noncurrent Liabilities
Total liabilities:3104484227,444
Stockholders' equity
Stockholders' equity attributable to parent, including:388268820(7,412)
Preferred stock  11
Common stock14141313
Common stock, share subscribed but unissued, subscriptions receivable(249)   
Additional paid in capital13,94412,70010,1201,287
Accumulated deficit(15,052)(13,417)  
Warrants and rights outstanding 15,69915,84910,614
Other undisclosed stockholders' equity attributable to parent1,731(14,729)(25,164)(19,325)
Total stockholders' equity:388268820(7,412)
TOTAL LIABILITIES AND EQUITY:6987161,24132

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Gross profit:24   
Operating expenses(1,647)(2,742)(1,954)(1,312)
Other undisclosed operating loss(24)   
Operating loss:(1,647)(2,742)(1,954)(1,312)
Nonoperating income (expense)12(5)(2)1
Investment income, nonoperating 11 
Other nonoperating income (expense)12(6)(3)1
Loss from continuing operations before equity method investments, income taxes:(1,635)(2,748)(1,956)(1,311)
Other undisclosed income (loss) from continuing operations before income taxes (1)(1)0
Net loss attributable to parent:(1,635)(2,748)(1,957)(1,311)
Other undisclosed net loss available to common stockholders, basic(761)   
Net loss available to common stockholders, diluted:(2,396)(2,748)(1,957)(1,311)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(1,635)(2,748)(1,957)(1,311)
Comprehensive loss, net of tax, attributable to parent:(1,635)(2,748)(1,957)(1,311)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: